ICU Medical (NASDAQ:ICUI) Upgraded at StockNews.com

StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a research report report published on Wednesday.

Other research analysts have also recently issued reports about the company. Raymond James set a $97.00 target price on ICU Medical in a research report on Wednesday, March 12th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, ICU Medical presently has a consensus rating of “Buy” and an average price target of $168.67.

ICU Medical Stock Performance

ICUI stock opened at $138.67 on Wednesday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical has a 1 year low of $93.36 and a 1 year high of $196.26. The company has a market cap of $3.40 billion, a P/E ratio of -30.34 and a beta of 0.86. The stock’s fifty day moving average price is $146.34 and its 200-day moving average price is $159.75.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in ICU Medical by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock worth $416,176,000 after acquiring an additional 17,805 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of ICU Medical by 7.4% during the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock valued at $109,920,000 after buying an additional 49,108 shares in the last quarter. Geode Capital Management LLC boosted its holdings in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after buying an additional 48,106 shares during the period. Dimensional Fund Advisors LP increased its stake in ICU Medical by 18.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock worth $83,788,000 after buying an additional 82,982 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in ICU Medical by 11.1% during the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier’s stock valued at $62,431,000 after acquiring an additional 40,187 shares during the period. Institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.